About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Tennessee | 18,974 Studies Near You

Clinical TrialsTennessee

Clinical Trials in Tennessee

Discover 18,974 clinical trials near Tennessee. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 4301-4320 of 18,974 trials

CompletedCevimeline in Treating Patients With Dry Mouth Caused by Radiation Therapy for Head and Neck CancerRATIONALE: Cevimeline may be effective in treating dry mouth that is caused by radiation therapy for head and neck cancer.NCT00017511·Birmingham, Alabama and 70 others

Find Trials by Condition in Tennessee

Breast Cancerin Tennessee Lung Cancerin Tennessee Prostate Cancerin Tennessee Colorectal Cancerin Tennessee Melanomain Tennessee Leukemiain Tennessee Lymphomain Tennessee Pancreatic Cancerin Tennessee Ovarian Cancerin Tennessee Brain Cancerin Tennessee

Data from ClinicalTrials.govTerms

TerminatedTAK-875 (Fasiglifam) in Combination With Sitagliptin in Adults With Type 2 DiabetesThe purpose of this study is to evaluate the effect of TAK-875 (fasiglifam) in combination with sitagliptin on glycemic control in adults with type 2 diabetes.NCT01829464·Birmingham, Alabama and 85 others

CompletedFixed 100 mg Every Evening of Flibanserin vs Placebo in Premenopausal Women With Hypoactive Sexual Desire DisorderThe object of this trial is to assess the safety and efficacy of a 24 week course of flibanserin for the treatment of hypoactive sexual desire disorder in premenopausal women.NCT00996164·Birmingham, Alabama and 74 others

CompletedStudy of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)To compare the effect of OPC-34712 (brexpiprazole) to the effect of placebo (an inactive substance) as add on treatment to an assigned FDA approved antidepressant treatment (ADT)…NCT01360632·Birmingham, Alabama and 70 others

RecruitingSurovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHLThis is a Phase 2 global, multi-center, open-label study to assess the efficacy, safety and tolerability of surovatamig (AZD0486) monotherapy in adult participants with…NCT06526793·Phoenix, Arizona and 93 others

TerminatedVaccine-Based Immunotherapy Regimen For NSCLC and TNBCPart 1of the study will evaluate the safety, pharmacokinetics, pharmacodynamics and immunogenicity of increasing doses of a vaccine-based immunotherapy regimen (VBIR-2) for…NCT03674827·Encinitas, California and 33 others

UnknownMIPE for Pilonidal DiseasePilonidal disease often presents as a chronic, relapsing condition.NCT03772873·Chicago, Illinois and 9 others

RecruitingPain Type and Interstitial Cystitis/Bladder Pain Syndrome TreatmentInterstitial cystitis/bladder pain syndrome (IC/BPS) is a severe pain condition affecting 3-8 million people in the United States lacking treatments that work.NCT06299683·Franklin, Tennessee

CompletedSTOP Persistent AFTo demonstrate safety and effectiveness of the Arctic Front Advance™ and Freezor MAX® Cardiac CryoAblation Catheters for the treatment of drug refractory recurrent symptomatic…NCT03012841·Phoenix, Arizona and 24 others

CompletedEfficacy/Safety Study of ACTIQ® for Opioid-Tolerant Children and Adolescents With Breakthrough Pain (BTP)The primary objective of the study is to evaluate the efficacy of ACTIQ treatment for the management of breakthrough pain (BTP) compared to placebo treatment in children with…NCT00236041·Little Rock, Arkansas and 30 others

Approved for marketingDeflazacort Expanded Access Program for Children, Adolescents and Adults With Duchenne Muscular DystrophyThe expanded access program will provide access to treatment with deflazacort in children, adolescent, and adult patients with DMD in the U.S. who are ineligible, unable, or…NCT02592941·Phoenix, Arizona and 41 others

RecruitingAccelerated Flap Coverage in Severe Lower Extremity TraumaThe goal of this randomized controlled trial is to determine if accelerated flap coverage compared to standard flap coverage timing leads to improved infection-related…NCT06293469·Sacramento, California and 10 others

RecruitingStudy to Evaluate the Safety and Tolerability of Camizestrant in Combination With Atirmociclib in Women With Advanced Breast CancerA study to investigate camizestrant in combination with atirmociclib in participants with estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative…NCT07427394·St Louis, Missouri and 5 others

CompletedA Study Evaluating the Efficacy and Safety of Adding Symlin® to Lantus® (Insulin Glargine) in Subjects With Type 2 DiabetesThe purpose of this study is to evaluate the efficacy and safety of adding Symlin to an established regimen of insulin glargine in subjects with type 2 diabetes who are not…NCT00240253·Phoenix, Arizona and 33 others

CompletedStudy of CHS-388 (Formerly Known as SRF388) in Patients With Advanced Solid TumorsThis is a Phase 1/1b, open-label, first-in-human, dose-escalation and expansion study of CHS-388, a monoclonal antibody that targets IL-27, as a monotherapy and in combination in…NCT04374877·Duarte, California and 22 others

TerminatedRandomized, Double-Blind, Placebo-Controlled Trial of REL-1017 as Adjunctive Treatment for MDDA Phase 3, randomized, double-blind, placebo-controlled, multicenter trial of REL-1017 in patients with major depressive disorder (MDD).NCT06011577·Dothan, Alabama and 35 others

Completed16 Week Efficacy and 5 Year Long Term Efficacy, Safety and Tolerability of Secukinumab in Patients With Active Ankylosing SpondylitisThis study assessed the efficacy and safety of secukinumab in patients with active ankylosing spondylitis who were tolerant to or had an inadequate response to NSAIDs, DMARDs and…NCT01649375·Mesa, Arizona and 52 others

CompletedFludarabine Followed by Alemtuzumab in Treating Patients With Chronic Lymphocytic LeukemiaRATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die.NCT00004857·Birmingham, Alabama and 49 others

CompletedA 52-week International, Multicenter Trial With a Long -Term Extension to Evaluate Saxagliptin With Dapagliflozin in Combination With Metformin Compared to Glimepiride in Combination With Metformin in Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin AloneThis clincial trial is evaluating if the co-administration of saxagliptin and dapagliflozin, in addition to metformin, results in better glycemic control, as measured by HbA1c…NCT02419612·Birmingham, Alabama and 83 others

Active not recruitingAbbott Ventricular Tachycardia PASThis post-approval study (PAS) is designed to provide continued clinical evidence to confirm the long-term safety and effectiveness of the FlexAbilityTM Ablation Catheter, Sensor…NCT05839873·Naples, Florida and 10 others

PreviousPage 216 of 949Next

Diabetes

in Tennessee

Heart Diseasein Tennessee